ORLANDO IMMUNOLOGY CENTER
๐บ๐ธUnited States
A Pharmacist-run PrEP Program for Women
Terminated
- Conditions
- HIV Prevention
- Interventions
- Drug: LA-CABDrug: TDF/FTC
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Orlando Immunology Center
- Target Recruit Count
- 2
- Registration Number
- NCT05755204
- Locations
- ๐บ๐ธ
Orlando Immunology Center, Orlando, Florida, United States
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
- First Posted Date
- 2022-02-02
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Orlando Immunology Center
- Target Recruit Count
- 50
- Registration Number
- NCT05220358
- Locations
- ๐บ๐ธ
Orlando Immunology Center, Orlando, Florida, United States
Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2006-04-07
- Last Posted Date
- 2008-05-22
- Lead Sponsor
- Orlando Immunology Center
- Target Recruit Count
- 20
- Registration Number
- NCT00312169
- Locations
- ๐บ๐ธ
Greenville Hospital System Infectious Disease Associates, Greenville, South Carolina, United States
๐บ๐ธRicky Hsu, MD, New York, New York, United States
๐บ๐ธAltaMed Health Services Corporation, Los Angelos, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath